US Stock MarketDetailed Quotes

IBRX ImmunityBio

Watchlist
  • 6.940
  • +0.135+1.98%
Close May 22 16:00 ET
  • 6.990
  • +0.050+0.72%
Post 19:55 ET
4.80BMarket Cap-6425P/E (TTM)

About ImmunityBio Company

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolIBRX
Company NameImmunityBio
Listing DateJul 28, 2015
Issue Price25.00
Founded2014
CEOMr. Richard Adcock
MarketNASDAQ
Employees628
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3530 John Hopkins Court
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-844-696-5235
Websitehttp://www.immunitybio.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard Adcock
  • Chief Executive Officer, President and Director
  • 1.16M
  • Regan J. Lauer
  • Chief Accounting Officer
  • --
  • David C. Sachs
  • Chief Financial Officer
  • 1.06M
  • Dr. Patrick Soon-Shiong, F.A.C.S.,M.D.
  • Executive Chairman of the Board, Global Chief Scientific and Medical Officer
  • 865.34K
  • Dr. Barry J. Simon, M.D.
  • Chief Corporate Affairs Officer and Director
  • --
  • Christobel Selecky
  • Independent Director
  • 470.00K
  • General Sir Wesley Kanne Clark
  • Independent Director
  • 465.00K
  • Dr. Linda Maxwell, M.B.A.,M.D.
  • Independent Director
  • 487.50K
  • John Owen Brennan
  • Independent Director
  • 472.50K
  • Cheryl L. Cohen
  • Lead Independent Director
  • 506.25K
  • Michael D. Blaszyk
  • Independent Director
  • 510.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg